Sign in
4

Changes in Ownership

Lyell Immunopharma, Inc. Filed Acc 0001209191-24-003276

Chief Business Officer acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Lang Matthew · Chief Business Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-09 Grant or award : show line 1 in the form +50,000 50,000 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-09 Grant or award : show line 2 in the form Option (right to buy) +500,000 500,000 D
Loading xslF345X05/doc4.xml…